Log in to search using one of your social media accounts:

 

Increasing incidence of HIV ‐ associated tuberculosis in Romanian injecting drug users
BackgroundA high prevalence of tuberculosis (TB) among HIV‐positive injecting drug users (IDUs) may fuel the TB epidemic in the general population of Romania. We determined the frequency and characteristics of TB in HIV‐infected IDUs referred to a national centre. MethodsProspective observational cohort study of all newly‐diagnosed HIV‐positive IDUs admitted to Victor Babes Hospital, Bucharest, between January 2009 and December 2014. Socio‐demographics, clinical characteristics and outcomes of HIV/TB co‐infected IDUs were compared to HIV‐positive IDUs without TB. Results170/598 (28.5%) HIV‐infected IDUs wer...
Source: HIV Medicine - February 21, 2018 Category: Infectious Diseases Authors: C Oprea, I Ianache, PI Calistru, M Nica, S Ruta, C Smith, M Lipman Tags: Original Research Source Type: research

Issue Information
(Source: HIV Medicine)
Source: HIV Medicine - February 21, 2018 Category: Infectious Diseases Tags: Issue Information Source Type: research

HIV: ageing, cognition and neuroimaging at 4 ‐year follow‐up
ConclusionsIn the present study, we found some evidence for accelerated ageing in HIV‐positive individuals, with a statistically significant HIV status by age group interaction in global cognition, although this interaction could not be explained by the imaging findings. Moreover, we also found that change in cognitive performance was correlated with change in the DTI measures, and this effect was stronger for the HIV‐positive participants. This will need replication in larger studies using a similarly lengthy follow‐up period. (Source: HIV Medicine)
Source: HIV Medicine - February 1, 2018 Category: Infectious Diseases Authors: BI Haynes, M Pitkanen, R Kulasegaram, SJ Casey, M Schutte, K Towgood, B Peters, GJ Barker, MD Kopelman Tags: Original Research Source Type: research

Long ‐term effectiveness of recommended boosted protease inhibitor‐based antiretroviral therapy in Europe
ObjectivesThe aim of the study was to evaluate the long‐term response to antiretroviral treatment (ART) based on atazanavir/ritonavir (ATZ/r)‐, darunavir/ritonavir (DRV/r)‐, and lopinavir/ritonavir (LPV/r)‐containing regimens. MethodsData were analysed for 5678 EuroSIDA‐enrolled patients starting a DRV/r‐, ATZ/r‐ or LPV/r‐containing regimen between 1 January 2000 and 30 June 2013. Separate analyses were performed for the following subgroups of patients: (1) ART‐naïve subjects (8%) at ritonavir‐boosted protease inhibitor (PI/r) initiation; (2) ART‐experienced individuals (44%) initiating the new P...
Source: HIV Medicine - February 1, 2018 Category: Infectious Diseases Authors: JR Santos, A Cozzi ‐Lepri, A Phillips, S De Wit, C Pedersen, P Reiss, A Blaxhult, A Lazzarin, M Sluzhynska, C Orkin, C Duvivier, J Bogner, P Gargalianos‐Kakolyris, P Schmid, G Hassoun, I Khromova, M Beniowski, V Hadziosmanovic, D Sedlacek, R Paredes, Tags: Original Research Source Type: research

An outbreak of acute hepatitis A among young adult men: clinical features and HIV coinfection rate from a large teaching hospital in Rome, Italy
ConclusionsIn 2016–2017, we saw a rise in the number of hepatitis A cases, with a higher prevalence of adult male patients. No significant differences regarding the prevalence of HIV coinfection emerged. (Source: HIV Medicine)
Source: HIV Medicine - January 30, 2018 Category: Infectious Diseases Authors: A Ciccullo, R Gagliardini, G Baldin, A Borghetti, D Moschese, A Emiliozzi, F Lombardi, R Ricci, D Speziale, F Pallavicini, S Di Giambenedetto Tags: Original Research Source Type: research

Rates of sustained virological response 12  weeks after the scheduled end of direct‐acting antiviral (DAA)‐based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy?
ObjectivesThe European Association for the Study of the Liver (EASL) treatment recommendations for hepatitis C no longer discriminate between HIV/hepatitis C virus (HCV)‐coinfected and HCV‐monoinfected patients. However, recent data from Spain are questioning these recommendations on the basis of the findings of higher relapse rates and lower cure rates in HIV/HCV‐infected subjects. The aim of our study was to compare HCV cure rates in monoinfected and coinfected patients from Germany. MethodsData acquired from the Deutsches Hepatitis C‐Registry were analysed. A total of 5657 HCV‐monoinfected subjects and 488 HIV...
Source: HIV Medicine - January 25, 2018 Category: Infectious Diseases Authors: J Bischoff, S Mauss, C Cordes, T Lutz, S Scholten, A Moll, H J äger, M Cornberg, MP Manns, A Baumgarten, JK Rockstroh Tags: Original Research Source Type: research

The world ‐wide incidence of Kaposi's sarcoma in the HIV/AIDS era
ConclusionsGlobally, a relatively high incidence of KS was found among HIV‐seropositive people and, in particular, in HIV‐infected MSM. The introduction of HAART has largely prevented the development of KS, but it has not entirely removed the challenge of KS. In Africa, in particular, KS imposes a very heavy disease burden, which can mainly be attributed to the high prevalence of KS‐associated herpesvirus and poor access to HAART. (Source: HIV Medicine)
Source: HIV Medicine - January 25, 2018 Category: Infectious Diseases Authors: Z Liu, Q Fang, J Zuo, V Minhas, C Wood, T Zhang Tags: Original Research Source Type: research

Patient perspectives on de ‐simplifying their single‐tablet co‐formulated antiretroviral therapy for societal cost savings
ConclusionsDe‐simplifying Triumeq® generates large cost savings. Additional savings could be achieved by de‐simplifying other STFs. Both physicians and patients agreed that selective de‐simplification was acceptable; however, it may not be acceptable to every patient. Monitoring the medical and cost impacts of de‐simplification strategies seems warranted. (Source: HIV Medicine)
Source: HIV Medicine - January 25, 2018 Category: Infectious Diseases Authors: HB Krentz, S Campbell, VC Gill, MJ Gill Tags: Original Research Source Type: research

Cerebrospinal fluid HIV RNA in persons living with HIV
ObjectivesDespite adequate suppression of plasma HIV RNA, viral escape in cerebrospinal fluid (CSF) is widely reported. Rates of CSF HIV RNA escape vary in the literature. In persons living with HIV (PLWH) undergoing lumbar puncture examination for clinical reasons, we assessed rates of CSF HIV RNA escape. MethodsPersons living with HIV attending a designated HIV neurology service undergoing CSF assessment for clinical reasons between January 2015 and April 2017 were included in the study. CSF HIV RNA escape was defined as HIV RNA ≥ 0.5 log10 HIV‐1 RNA copies/mL higher than plasma HIV RNA or detectable CSF HIV RN...
Source: HIV Medicine - January 25, 2018 Category: Infectious Diseases Authors: M Di Carlofelice, A Everitt, D Muir, A Winston Tags: Short Communication Source Type: research

Sexualized drug use ( ‘chemsex’) and high‐risk sexual behaviours in HIV‐positive men who have sex with men
ObjectivesThe incidence of sexually transmitted infections (STIs) and HIV infection remains high in gay, bisexual, and other men who have sex with men (MSM) in the UK, and sexualized drug use (“chemsex”) and injecting drug use (“slamsex”) may play a part in this. We aimed to characterize HIV‐positive MSM engaging in chemsex/slamsex and to assess the associations with self‐reported STI diagnoses and sexual behaviours. MethodsData from a 2014 survey of people attending HIV clinics in England and Wales were linked to clinical data from national HIV surveillance records and weighted to be nationally...
Source: HIV Medicine - January 24, 2018 Category: Infectious Diseases Authors: EL Pufall, M Kall, M Shahmanesh, A Nardone, R Gilson, V Delpech, H Ward, Tags: Original Research Source Type: research

‘Get an early check – Chrysanthemum tea’: An outcome evaluation of a multimedia campaign promoting HIV testing among men who have sex with men in Hong Kong
ConclusionsThe campaign had relatively good reach in the target population and may have been useful to encourage them to take up HIV testing. Future campaigns promoting HIV testing among MSM in Hong Kong are still needed. Such programmes should consider making use of viral videos, having a longer project duration and developing culturally sensitive materials for non‐Chinese‐speaking MSM. (Source: HIV Medicine)
Source: HIV Medicine - January 24, 2018 Category: Infectious Diseases Authors: NNM Kwan, AMH Wong, Y Fang, Z Wang Tags: Original Research Source Type: research

Clinical use of brain magnetic resonance imaging for neurological symptoms in people living with HIV
(Source: HIV Medicine)
Source: HIV Medicine - January 19, 2018 Category: Infectious Diseases Authors: L Kent, A Amlani, S Vundavalli, BH Ridha, JH Vera Tags: Letter to the Editor Source Type: research

Neglect of attention to reproductive health in women with HIV infection: contraceptive use and unintended pregnancies in the Swiss HIV Cohort Study
ConclusionsFamily planning needs in HIV‐positive women are not fully addressed because male condoms remained the predominant reported contraceptive method, with a high rate of unintended pregnancies. It is of utmost importance to provide effective contraception such as long‐acting reversible contraceptives for women living with HIV. (Source: HIV Medicine)
Source: HIV Medicine - January 16, 2018 Category: Infectious Diseases Authors: K Aebi ‐Popp, V Mercanti, C Voide, J Nemeth, A Cusini, B Jakopp, D Nicca, M Rasi, A Bruno, A Calmy, B Martinez de Tejada, Tags: Original Research Source Type: research

National audit of perinatal HIV infections in the UK, 2006 –2013: what lessons can be learnt?
ConclusionsPriority areas requiring improvement include reducing incident infections, improving ART adherence and facilitating better engagement in care, with attention to addressing the health inequalities and adverse social situations faced by these women. (Source: HIV Medicine)
Source: HIV Medicine - January 16, 2018 Category: Infectious Diseases Authors: H Peters, C Thorne, PA Tookey, L Byrne Tags: Original Research Source Type: research

Issue Information
(Source: HIV Medicine)
Source: HIV Medicine - January 12, 2018 Category: Infectious Diseases Tags: Issue Information Source Type: research

HIV prevalence among first ‐presentation psychotic patients
ObjectivesFirst‐episode psychosis is a frequent emergency department (ED) presentation that may potentially be secondary to an underlying life‐threatening HIV‐related condition. The aim of this study was to determine the prevalence of HIV infection in patients presenting with a first episode of psychosis. MethodsMedical records of 159 consecutive African, Asian, White and mixed ethnicity patients presenting to a tertiary academic hospital ED with a first episode of psychotic features were prospectively reviewed. ResultsOf the 159 subjects, 63 (39.6%) were HIV positive. An underlying medical condition was the most com...
Source: HIV Medicine - December 28, 2017 Category: Infectious Diseases Authors: A Laher, N Ariefdien, Y Etlouba Tags: Original Research Source Type: research

Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort
ConclusionsABC remains commonly used across Europe and the incidence of discontinuation because of reported HSR was low in our study population. (Source: HIV Medicine)
Source: HIV Medicine - December 22, 2017 Category: Infectious Diseases Authors: A Roen, K Laut, A Pelchen ‐Matthews, E Borodulina, L Caldeira, A Clarke, B Clotet, A d'Arminio Monforte, G Fätkenheuer, JM Gatell Artigas, I Karpov, A Kuznetsova, G Kyselyova, I Mozer‐Lisewska, F Mulcahy, L Ragone, A Scherrer, V Uzdaviniene, L Vandek Tags: Original Research Source Type: research

Efficacy, safety and patient ‐reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor‐experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study)
ObjectivesStudies evaluating the efficacy and safety of the fixed‐dose combination ledipasvir (LDV)/sofosbuvir (SOF) in patients coinfected with HIV‐1 and hepatitis C virus (HCV) have mainly included treatment‐naïve patients without cirrhosis. We aimed to evaluate the efficacy and safety of this combination in treatment‐experienced patients with and without cirrhosis. MethodsWe conducted a multicentre, open‐label, double‐arm, nonrandomized study in patients coinfected with HIV‐1 and HCV genotype 1 with and without cirrhosis, who had good viral suppression on their antiretroviral regimens. All patients we...
Source: HIV Medicine - December 7, 2017 Category: Infectious Diseases Authors: E Rosenthal, C Fougerou ‐Leurent, A Renault, MP Carrieri, F Marcellin, R Garraffo, E Teicher, H Aumaitre, K Lacombe, F Bailly, E Billaud, S Chevaliez, S Dominguez, MA Valantin, J Reynes, A Naqvi, L Cotte, S Metivier, V Leroy, M Dupon, T Allegre, P De Tr Tags: Original Research Source Type: research

Screening for human papillomavirus, cervical cytological abnormalities and associated risk factors in HIV ‐positive and HIV‐negative women in Rwanda
ConclusionsThe currently used quadrivalent vaccine may be insufficient to give satisfactory HPV coverage in Rwanda. HPV Screening may be effective to identify women at risk of developing cervical cancer, particularly if provided to high‐risk patients. (Source: HIV Medicine)
Source: HIV Medicine - December 6, 2017 Category: Infectious Diseases Authors: MF Mukanyangezi, V Sengpiel, O Manzi, G Tobin, S Rulisa, E Bienvenu, D Giglio Tags: Original Research Source Type: research

HbAHP ‐25 attenuates HIV‐1 gp120 mediated inflammation and barrier dysfunction
ConclusionHbAHP‐25 is exceedingly safe to genital epithelial cells and attenuates HIV‐1 gp120‐mediated barrier dysfunction by limiting excessive inflammation. This study provides significant evidences in the favor of HbAHP‐25's potential as a topical anti‐HIV agent. (Source: HIV Medicine)
Source: HIV Medicine - December 6, 2017 Category: Infectious Diseases Authors: T Bashir, KVR Reddy Tags: Original Research Source Type: research

Issue Information
(Source: HIV Medicine)
Source: HIV Medicine - December 4, 2017 Category: Infectious Diseases Tags: Issue Information Source Type: research

Management of drug interactions with direct ‐acting antivirals in Dutch HIV/hepatitis C virus‐coinfected patients: adequate but not perfect
ConclusionsPrescription patterns suggest that physicians are aware of potential DDIs between co‐medication and DAAs, in particular potential DDIs with cART. Greater awareness is needed concerning category 3 interactions between non‐cART co‐medication and DAAs. (Source: HIV Medicine)
Source: HIV Medicine - December 1, 2017 Category: Infectious Diseases Authors: EJ Smolders, C Smit, CTMM Kanter, ASM Dofferhoff, JE Arends, K Brinkman, B Rijnders, M Valk, P Reiss, DM Burger, Tags: Original Research Source Type: research

Improvement in lipids after switch to boosted atazanavir or darunavir in children/adolescents with perinatally acquired HIV on older protease inhibitors: results from the Pediatric HIV/AIDS Cohort Study
ConclusionsA switch to ATV/r or DRV/r may result in more rapid reduction in TC and the TC:HDL‐C ratio in PHIV youth, potentially impacting long‐term cardiovascular disease risk. (Source: HIV Medicine)
Source: HIV Medicine - November 21, 2017 Category: Infectious Diseases Authors: J Jao, W Yu, K Patel, TL Miller, B Karalius, ME Geffner, LA DiMeglio, A Mirza, JS Chen, M Silio, EJ McFarland, RB Van Dyke, D Jacobson, Tags: Original Research Source Type: research

Antiretroviral pill count and clinical outcomes in treatment ‐naïve patients with HIV infection
ConclusionsThis particular single‐tablet regimen is associated with a modest decrease in the risk of AIDS or death relative to multiple‐pill formulations. (Source: HIV Medicine)
Source: HIV Medicine - November 6, 2017 Category: Infectious Diseases Authors: J Young, C Smith, R Teira, P Reiss, I Jarr ín Vera, H Crane, JM Miro, A D'Arminio Monforte, M Saag, R Zangerle, HC Bucher, Tags: Original Research Source Type: research

Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV ‐1 positive patients with well‐estimated dates of seroconversion
ConclusionsCD4 count at cART initiation is the most important factor in predicting post‐treatment recovery, but VL provides substantial additional information. If cART is initiated in the first 4 months following seroconversion, recovery of CD4 counts appears to be more rapid. (Source: HIV Medicine)
Source: HIV Medicine - November 1, 2017 Category: Infectious Diseases Authors: OT Stirrup, AJ Copas, AN Phillips, MJ Gill, RB Geskus, G Touloumi, J Young, HC Bucher, AG Babiker, Tags: Original Research Source Type: research

Pre ‐exposure prophylaxis: awareness, acceptability and risk compensation behaviour among men who have sex with men and the transgender population
ConclusionsWith high acceptability and a low likelihood of risk compensation behaviour, PrEP can be considered as an effective prevention strategy for HIV infection among MSM and TGs in India. (Source: HIV Medicine)
Source: HIV Medicine - November 1, 2017 Category: Infectious Diseases Authors: CK Uthappa, RR Allam, R Pant, S Pal, M Dinaker, G Oruganti, VV Yeldandi Tags: Original Research Source Type: research

Hospital ‐based routine HIV testing in high‐income countries: a systematic literature review
ConclusionsThere are several barriers to routine HIV testing in EDs and AMUs. Many of these stem from staff fears about offering HIV testing due to the perceived lack of knowledge about HIV. Our systematic review highlights areas which can be targeted to increase coverage of routine HIV testing. (Source: HIV Medicine)
Source: HIV Medicine - November 1, 2017 Category: Infectious Diseases Authors: A Elgalib, S Fidler, K Sabapathy Tags: Original Research Source Type: research

Promoting high standards of care for women living with HIV: position statement from the Women Against Viruses in Europe Working Group
ConclusionsThis position statement provides an overview of the key recommendations to optimize the care of WLWH that emerged during the 2016 WAVE workshop. (Source: HIV Medicine)
Source: HIV Medicine - November 1, 2017 Category: Infectious Diseases Authors: JD Kowalska, K Aebi ‐Popp, M Loutfy, FA Post, MJ Perez‐Elias, M Johnson, F Mulcahy, Tags: Reviews In Antiretroviral Research Source Type: research

Vitamin D and progression of carotid intima ‐media thickness in HIV‐positive Canadians
ObjectivesBased on a growing body of evidence implicating low vitamin D status in the development of cardiovascular disease (CVD), we hypothesized that in Canadian HIV‐positive adults, low 25‐hydroxyvitamin D (25(OH)D) concentration would be associated with increased subclinical vascular disease progression. MethodsWe prospectively studied the relationship between baseline 25(OH)D and subsequent progression of carotid intima‐media thickness (CIMT) between 2002 and 2011, in the Canadian HIV Vascular Study using stored blood specimens. ResultsOf the 128 participants, 89.1% were men, the mean age (standard deviation [SD...
Source: HIV Medicine - November 1, 2017 Category: Infectious Diseases Authors: H Huff, AT Merchant, E Lonn, E Pullenayegum, F Smaill, M Smieja Tags: Original Research Source Type: research

Food insecurity may lead to incomplete HIV viral suppression and less immune reconstitution among HIV/hepatitis C virus ‐coinfected people
ConclusionsThese findings provide evidence of the negative impact of food insecurity on HIV viral load and CD4 count among HIV/HCV‐coinfected people. (Source: HIV Medicine)
Source: HIV Medicine - November 1, 2017 Category: Infectious Diseases Authors: W Aibibula, J Cox, A ‐M Hamelin, EEM Moodie, AI Naimi, T McLinden, MB Klein, P Brassard, Tags: Original Research Source Type: research

European AIDS Clinical Society Second Standard of Care Meeting, Brussels 16 ‐17 November 2016: a summary
The European AIDS Clinical Society (EACS) organized a second meeting on Standard of Care in Europe on November 16‐17 th, 2016. The aims of the meeting were to discuss and propose actions on three topics, namely: Adherence to guidelines for treatment initiation, treatment monitoring and outcomes, Retention in care and HIV and tuberculosis co‐infection. Several actions need to be implemented in order to further improve quality of care and treatment of HIV in Europe. A common ground for standard of care, based on the EACS Guidelines should be established throughout Europe. EACS plans to interact with policy makers and oth...
Source: HIV Medicine - October 27, 2017 Category: Infectious Diseases Authors: S De Wit, M Battegay, A D'Arminio Monforte, JD Lundgren, C Oprea, A Antinori, S Bhagani, G F ätkenheuer, N Friis‐Moller, H Furrer, C Mussini, Tags: Original Research Source Type: research

A note of thanks to referees for Volume 18, 2017
(Source: HIV Medicine)
Source: HIV Medicine - October 16, 2017 Category: Infectious Diseases Tags: Miscellaneous Source Type: research

Table of Contents
(Source: HIV Medicine)
Source: HIV Medicine - October 16, 2017 Category: Infectious Diseases Tags: Issue Information Source Type: research

Editorial Board
(Source: HIV Medicine)
Source: HIV Medicine - October 16, 2017 Category: Infectious Diseases Tags: Issue Information Source Type: research

Incidence of cancer and overall risk of mortality in individuals treated with raltegravir ‐based and non‐raltegravir‐based combination antiretroviral therapy regimens
ConclusionsWe found no evidence for an oncogenic risk or poorer survival associated with using RAL compared with control groups. (Source: HIV Medicine)
Source: HIV Medicine - October 6, 2017 Category: Infectious Diseases Authors: A Cozzi ‐Lepri, R Zangerle, L Machala, K Zilmer, M Ristola, C Pradier, O Kirk, H Sambatakou, G Fätkenheuer, I Yust, P Schmid, M Gottfredsson, I Khromova, D Jilich, R Flisiak, J Smidt, B Rozentale, R Radoi, MH Losso, JD Lundgren, A Mocroft, Tags: Original Research Source Type: research

The role of frequent HIV testing in diagnosing HIV in men who have sex with men
ConclusionsThe probability of subsequent HIV diagnosis was greatest in high‐risk MSM who were tested most frequently. Quarterly HIV testing increased the likelihood of identifying undiagnosed HIV infection and should remain a continued recommendation for high‐risk MSM. (Source: HIV Medicine)
Source: HIV Medicine - October 1, 2017 Category: Infectious Diseases Authors: M Furegato, H Mitchell, D Ogaz, S Woodhall, N Connor, G Hughes, A Nardone, H Mohammed Tags: Original Research Source Type: research

Table of Contents
(Source: HIV Medicine)
Source: HIV Medicine - September 4, 2017 Category: Infectious Diseases Tags: Issue Information Source Type: research

Editorial Board
(Source: HIV Medicine)
Source: HIV Medicine - September 4, 2017 Category: Infectious Diseases Tags: Issue Information Source Type: research

The extent of B ‐cell activation and dysfunction preceding lymphoma development in HIV‐positive people
ConclusionsFLC‐κ, FLC‐λ and IgG levels were higher> 2 years before lymphoma diagnosis, suggesting that B‐cell dysfunction occurs many years prior to lymphoma development. However, the predictive value of each marker was low and they are unlikely candidates for risk assessment for targeted intervention. (Source: HIV Medicine)
Source: HIV Medicine - August 31, 2017 Category: Infectious Diseases Authors: L Shepherd, ÁH Borges, R Harvey, M Bower, A Grulich, M Silverberg, J Weber, M Ristola, J‐P Viard, JR Bogner, P Gargalianos‐Kakolyris, C Mussini, K Mansinho, I Yust, D Paduta, D Jilich, T Smiatacz, R Radoi, J Tomazic, P Plomgaard, R Frikke‐Schmidt, Tags: Original Research Source Type: research

Reply to Letter ‘Morning dosing for dolutegravir‐related insomnia and sleep disorders’ by Capetti et al.
(Source: HIV Medicine)
Source: HIV Medicine - August 29, 2017 Category: Infectious Diseases Authors: C Hoffmann, T Welz, M Sabranski, M Kolb, E Wolf, H ‐J Stellbrink, C Wyen Tags: Letter to the Editor Source Type: research

Argon plasma coagulation treatment of anal high ‐grade squamous intraepithelial lesions in men who have sex with men living with HIV: results of a 2‐year prospective pilot study
ConclusionsAPC can be used to treat anal HSILs in HIV‐seropositive MSM, and requires repeated treatment because of a high recurrence rate. As successful treatment of human papillomavirus (HPV) infection or eradication of the anal transitional zone remains impossible, HSIL treatment is challenging and requires long‐term follow‐up. (Source: HIV Medicine)
Source: HIV Medicine - August 23, 2017 Category: Infectious Diseases Authors: A Pokomandy, D Rouleau, R Lalonde, C Beauvais, C Castro, F Coutl ée, Tags: Original Research Source Type: research

No relationship between late HIV diagnosis and social deprivation in newly diagnosed patients in France
Conclusions‘Population’ seems to be more relevant than EDI to define evidence‐based interventions to limit late diagnosis. (Source: HIV Medicine)
Source: HIV Medicine - August 18, 2017 Category: Infectious Diseases Authors: L Cuzin, Y Yazdanpanah, T Huleux, L Cotte, P Pugliese, C Allavena, J Reynes, I Poizot ‐Martin, F Bani‐Sadr, C Delpierre, Tags: Short Communication Source Type: research

HIV ‐infected patients' beliefs about their chronic co‐treatments in comparison with their combined antiretroviral therapy
ObjectivesThanks to the success of combination antiretroviral therapy (cART), HIV‐infected patients can have almost a normal life expectancy. This has resulted in an aging HIV‐infected population with other chronic comorbidities such as cardiovascular diseases, osteoporosis, and depression. Our hypothesis is that patients' perceptions of and attitudes towards their cART, which is perceived as crucial to their survival, differ from their beliefs about their co‐treatments, and this may have an impact on their medication adherence. MethodsWe used the French version of the Beliefs about Medicine Questionnaire (BMQ‐f) t...
Source: HIV Medicine - August 16, 2017 Category: Infectious Diseases Authors: S Kamal, O Bugnon, M Cavassini, MP Schneider Tags: Original Research Source Type: research

Are fluconazole or sertraline dose adjustments necessary with concomitant rifampin?
(Source: HIV Medicine)
Source: HIV Medicine - August 2, 2017 Category: Infectious Diseases Authors: R Rajasingham, DB Meya, DR Boulware Tags: Letter to the Editor Source Type: research

Morning dosing for dolutegravir ‐related insomnia and sleep disorders
(Source: HIV Medicine)
Source: HIV Medicine - August 1, 2017 Category: Infectious Diseases Authors: AF Capetti, S Di Giambenedetto, A Latini, G Sterrantino, I De Benedetto, MV Cossu, A Gori Tags: Letter to the Editor Source Type: research

Table of Contents
(Source: HIV Medicine)
Source: HIV Medicine - August 1, 2017 Category: Infectious Diseases Tags: Issue Information Source Type: research

Editorial Board
(Source: HIV Medicine)
Source: HIV Medicine - August 1, 2017 Category: Infectious Diseases Tags: Issue Information Source Type: research

HIV incidence in the Estonian population in 2013 determined using the HIV ‐1 limiting antigen avidity assay
ConclusionsThese high HIV incidence estimates in Estonia call for urgent action of renewed targeted public health promotion and HIV testing campaigns. (Source: HIV Medicine)
Source: HIV Medicine - August 1, 2017 Category: Infectious Diseases Authors: P Soodla, R Simmons, K Huik, M Pauskar, E ‐L Jõgeda, H Rajasaar, E Kallaste, M Maimets, R Avi, G Murphy, K Porter, I Lutsar, Tags: Original Research Source Type: research

Discordant rapid HIV tests: lessons from a low ‐resource community
ConclusionsWhen the sample occurrence of discordance between the first and second tests is below 5%, discordant rapid tests in an adult with sexual risk behaviour should trigger strong suspicion of early HIV infection in low HIV prevalence populations. (Source: HIV Medicine)
Source: HIV Medicine - July 31, 2017 Category: Infectious Diseases Authors: AA Adetunji, MA Kuti, RA Audu, SA Muyibi, M Imhansoloeva, OA Mosuro, EA Solanke, OM Akpa, AE Irabor, MMA Ladipo, B Berzins, K Robertson, A Ogunniyi, IF Adewole, BO Taiwo Tags: Short Communication Source Type: research

Severe depression as a neuropsychiatric side effect induced by dolutegravir
(Source: HIV Medicine)
Source: HIV Medicine - July 26, 2017 Category: Infectious Diseases Authors: H Scheper, N Holten, JGFM Hovens, MGJ Boer Tags: Letter to the Editor Source Type: research